When we talk about K-Beauty innovation, the focus often gravitates toward trending ingredients. However, efficacy is never driven by ingredients alone. It’s the result of sustained and iterative research, continuous formulation evolution and increasingly sophisticated delivery systems that determine how those ingredients actually perform on the skin and lead to meaningful formulations.
Delivery systems play a critical role because many actives are inherently unstable, poorly absorbed or effective only at specific skin depths. Without the right system, even the most promising ingredient may never reach its intended target. In this sense, efficacy is defined by the synergy between the active itself and the system delivering it.
Delivery Technologies at the Forefront of Innovation
Against this backdrop, three key delivery technologies underpin many of the current advances in K-Beauty innovation: liposomes, exosomes and spicules. Liposomes are microscopic, spherical vesicles made of lipids—the same building blocks that form our skin’s natural cell membranes. Because of that similarity, they are fundamentally biocompatible with the skin, making them especially effective delivery vehicles. Functionally, liposomes act like protective micro-reservoirs, encapsulating active ingredients such as vitamins, peptides, or antioxidants and shielding them from oxidation and environmental degradation before they reach the skin.
Liposomes also change how they interact with the skin. Liposomes can improve penetration by facilitating movement through the skin barrier, while enabling a more controlled, gradual release of actives once applied on skin. From a formulation standpoint, this allows for the delivery of high-performance actives in a way that is both effective and skin-comfortable—reducing irritation while maintaining efficacy. While liposomes are not new, their continued relevance lies in the increasing precision with which their size, structure, and release behavior can be engineered.
Last month, for example, Amorepacific shared its next-generation liposome delivery technology: Lipo3Ex.that incorporates plant-derived triterpenoids that naturally preserve the carrier's structure and fortify intermolecular bonds, The result is a lipid-based nano-delivery system with significantly reduced size and ultra stable liposomal architecture that is highly resistant to structural collapse. The system is designed to improve the delivery of active ingredients while maintaining structural stability that has historically limited ultra-small carriers. Human skin trials showed that this technology delivers active ingredients more evenly and effectively compared to conventional systems. The study also used advanced scientific analysis methods including cryo-electron microscopy and molecular simulations to validate the technology’s stability and performance. This technology was developed in collaboration with the Korea Advanced Institute of Science and Technology (KAIST) and was featured as the cover article in the May issue (Vol. 20, Issue 17) of the internationally acclaimed nanoscience journal, ACS Nano1 , and will soon be incorporated into new formulations under the Amorepacific portfolio.
Exosomes, by contrast, represent a fundamentally different concept. These are nano-sized extracellular vesicles that are naturally secreted by cells as part of biological communication. Rather than serving purely as carriers, exosomes function more like messengers, transporting signaling mediators and biomolecules that help coordinate cellular responses.
This distinction is critical. In skincare, exosomes are not simply delivery vehicles but bio-inspired components that support the skin’s own processes related to barrier function, recovery, and resilience. They are best understood as complementary elements within formulations rather than as primary actives. Notably, exosomes used in cosmetics today can be derived from diverse sources, including plant-based materials such as green tea, aligning with broader trends toward sustainability and consumer preference.
While liposomes and exosomes operate at chemical and biological levels, spicules introduce a physical dimension to delivery. These microscopic, needle-like structures create thousands of invisible micro-channels on the skin surface upon application. The process is controlled and non-invasive, often associated with a mild tingling sensation that has contributed to their recent virality on social media. These micro-channels act as “express pathways,” enabling active ingredients to reach deeper and more efficiently. At the same time, the gentle mechanical interaction stimulates natural skin renewal processes, supporting improvements in texture, smoothness, and radiance.
While often compared to microneedling, spicules differ significantly. Microneedling is a clinical procedure involving deeper penetration, potential micro-injury, and recovery downtime. Spicules, on the other hand, remain superficial and non-invasive, making them suitable for at-home use.
Spicules traditionally come from marine sources, primarily sponges, where they naturally form the skeleton of the organism and are composed largely of silica. As the category has evolved in K-Beauty alongside technical advancement, companies have now developed synthetic spicules as well. These lab-created alternatives allow formulators to have precise control over size, shape, purity and consistency, which is critical for safety and performance in topical skincare. These advancements have not only improved formulation precision but also opened the door to reimagining spicules as active delivery systems—transforming them from passive exfoliating structures into engineered carriers capable of enhancing the penetration and efficacy of key ingredients. Amorepacific’s Retijection spicule technology, for example, embeds retinol inside spicules for effective and stable delivery into the skin, with clinical testing demonstrating a 46% increase in absorption compared to formulations without spicules, based on instrumental results from a study of 30 participants. Designed to be smaller than conventional spicules and refined with smooth, rounded tips for a noticeably gentler feel on the skin, this innovative system has also been shown to reduce irritation by 80% compared to traditional sponge-derived spicules, as observed in a sensory evaluation of 31 participants assessing stinging and burning sensations following application to opposite cheeks over a 9-minute period.
Together, these delivery systems highlight a central theme in K-Beauty innovation: how ingredients are delivered is just as important as, if not more important than the ingredients used.
From Delivery to Actives: Innovation in Parallel
While delivery systems ensure that ingredients reach their target effectively, breakthroughs in K-Beauty also require continuous refinement of the actives themselves. Increasingly, the most impactful formulations emerge from the interplay between advanced delivery mechanisms and thoughtfully engineered ingredients.
PDRN (polydeoxyribonucleotide) exemplifies this shift. Traditionally derived from salmon DNA and widely used in injectable treatments in South Korea, PDRN has long been valued for supporting skin repair, hydration and elasticity in clinic settings.
With growing interest, PDRN has developed into its own category in topical applications, expanding accessibility beyond dermatology clinics. Sourcing and processing innovations are broadening the ingredient’s potential. For example, Amorepacific’s green-tea-lactobacillus–derived PDRN and BluePDRN extracted from a microalgal source, Chlorella protothecoides, represent advancements in both sustainability and scalability. Notably, BluePDRN engages biological pathways associated with cell proliferation, collagen accumulation, and tissue repair—highlighting its regenerative potential in topical use (see Figure 1).
Figure 1 - Images from a reconstructed human epidermis test, showing ingreased levels of protein market expression during BluePDRN induced skin regeneration when compared to that of a control group.Courtesy of Amorepacific
Research results showed that BluePDRN displayed wound closure effects equivalent to those of salmon-derived PDRN, with each molecule being approximately 1/20th the size of a salmon-derived PDRN molecule. It also promoted the expression of collagen accumulation and angiogenesis, both of which are essential for healthy skin. Like traditional animal-derived PDRNs, BluePDRN demonstrated skin regeneration efficacy through an adenosine A2A receptor (A2AR)-dependent mechanism.2 (see Figure 2)
Figure 2 - visual representation of tests results from Amorepacific R&I Center paper published in Dermatological Research, indicating that BluePDRN activates cell proliferation and angiogenesis pathways through A2AR-dependent mechanisms.Courtesy of Amorepacific
While emerging ingredients like PDRN draw attention, ongoing innovation in staple actives remains equally critical. Retinol, one of the most extensively studied ingredients in skincare, continues to evolve through formulation strategies. Current approaches include improving tolerability and efficacy through pairing and system design. For example, combining retinol with soothing ingredients such as cica helps mitigate irritation, while pairing with PDRN supports skin recovery.
More advanced systems like multi-retinoid complexes take this further by incorporating multiple forms of retinoids with varying absorption profiles. This enables more balanced and sustained activity while reducing the risks associated with high-dose single retinol formulations—effectively optimizing efficacy, stability and skin tolerance simultaneously.
Alternatively, new variations are also expanding the retinoid category. Amorepacific’s Seletinoid G, designed using molecular modeling to selectively target RAR-γ receptors, the predominant receptor subtype in the epidermis, is one example of a next-generation retinoid. Published findings demonstrate that Seletinoid G enhances keratinocyte proliferation, accelerates wound healing, and restores UV-induced collagen loss, supporting both epidermal regeneration and dermal matrix integrity. 3 Compared to conventional retinol, this receptor selectivity enables more skin-specific biological activity with improved tolerability, while its ability to directly modulate gene expression allows for more precise and efficient signaling without reliance on metabolic conversion. Together, these advancements reflect a broader transition from formulation-driven optimization to precision-engineered retinoid design, signaling that innovation within the retinoid category remains far from complete.
Vitamin C formulations project a similar trajectory. Long recognized for its brightening and antioxidant properties, innovation now centers on stabilization, delivery and synergistic combinations rather than concentration alone. Multi-component systems incorporating complementary antioxidants such as vitamin E and ferulic acid enhance overall performance, while advanced stabilization strategies enable even high concentrations to remain effective and tolerable.
Notably, Amorepacific’s patented composition (KR102008275B1) addresses one of vitamin C’s primary limitations—its inherent instability—by leveraging a phase-separated system that minimizes exposure to oxygen and external stressors.4 This approach significantly improves oxidative stability on concentrations above 20%, allowing for clinically meaningful concentrations of vitamin C to be delivered with greater consistency and efficacy. Together, these advances illustrate how formulation science continues to unlock the full potential of well-established actives.
Ginseng provides a compelling example, especially in K-Beauty, of how traditional ingredients are transformed through technical innovation. While deeply rooted in Korean heritage for its cultural significance and restorative properties, ginseng’s modern relevance is driven by research that demonstrates and continuously optimizes its efficacy. Proprietary bioconversion technology is able to transform naturally occurring ginsenosides into advanced new forms, like Amorepacific’s bio-converted Compound K, a form of ginsenoside that is significantly more bioavailable to the skin. This transformed active also improves/showcases inhibition of pro-inflammatory pathways and support for epidermal function under stress conditions such as UV exposure. Clinically demonstrated through in vivo studies, this translates into visible improvements in firmness, resilience, and moisture retention—demonstrating how heritage ingredients can achieve new levels of efficacy through scientific advancement.
With increasing recognition of inflammaging—chronic, low-grade inflammation as a driver of skin aging—as a key skincare concern, finding evidence-backed ingredients to counter low-level inflammation is key. One innovative skin aging analysis system developed by Amorepacific looks at the inflammatory cytokine Interleukin-17A (IL-17A) as an intrinsic aging factor and ultraviolet B (UVB) as an extrinsic factor, and confirmed that simultaneous stimulation by IL-17A and UVB significantly amplifies inflammaging phenomena and hastens the aging of the epidermis. The proprietary bio-converted Compound K effectively inhibits the production of these inflammatory cytokines and normalizes the functions of the epidermis impaired by aging.5
These developments underscore a consistent principle: the performance of an ingredient is defined not just by its presence, but by how it is stabilized, combined, and delivered.
Conclusion: Innovation as an Ongoing Process
Taken together, these developments highlight a defining characteristic of K-Beauty: innovation is not limited to discovering new ingredients. It is equally about reimagining how existing ingredients are formulated, processed, and delivered.
Even well-established actives can continually evolve through smart formulation strategies and new delivery systems. This dual focus allows K-Beauty to consistently improve both efficacy and user experience.
Ultimately, K-Beauty demonstrates that meaningful innovation lies not just in what is used, but in how it is combined, engineered, and brought to the skin—creating solutions that are both highly effective and gentle.
References
- Min, S.-B., Pi, B.S., Kim, S., Park, S., Kang, S., Lee, E.-S., Choi, J., Lee, S.-M., Han, Y., Song, C., & Choi, S.Q., et al. (2025, May). Triterpenoids bend and bind lipid membranes into 20 nm stable nanocages. ACS Nano, 20(17).
- Park, J.M., Nam, G.B., Lee, E.-S., Kim, H.-M., Kim, H., Myoung, K., Lee, J.E., Baek, H.S., Ko, J., & Lee, C.S., et al. (2025, Feb 24). Effects of Chlorella protothecoides-derived polydeoxyribonucleotides on skin regeneration and wound healing. Archives of Dermatological Research.
- Lee, E.S., Ahn, Y., Bae, I.H., Min, D., Park, N.H., Jung, W., Kim, S.H., Hong, Y.D., Park, W.S., & Lee, C.S., et al. (2020, Apr 30). Synthetic retinoid seletinoid G improves skin barrier function through wound healing and collagen realignment in human skin equivalents. International Journal of Molecular Sciences, 21(9) e3198.
- Hwang, Y.-G., Ahn, J.-H., Kim, Y.-S., Na, D.-S., Seo, B.-H., Cho, S.-A., Chae, B.-G., Choi, D.-W., & Han, S.-H., et al. (2019, Aug 07). Cosmetic composition comprising an antioxidant. Korea Patent KR102008275B1.
- Kim, A.Y., Jung, J.-Y., Kim, D., Cho, J.H., Hong, Y.D., Kim, H.-J., Cho, S.-Y., et al. (2025, May 25). Compound K suppresses epidermal aging induced by IL-17A treatment and UVB irradiation. Journal of Ginseng Research, 49(3) 326–330.
